David A Buchen - Net Worth and Insider Trading

David A Buchen Net Worth

The estimated net worth of David A Buchen is at least $19 Million dollars as of 2024-05-11. David A Buchen is the Chief Legal Officer-Global&Sec of Allergan PLC and owns about 97,373 shares of Allergan PLC (AGN) stock worth over $19 Million. Details can be seen in David A Buchen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David A Buchen has not made any transactions after 2013-08-29 and currently still holds the listed stock(s).

Transaction Summary of David A Buchen

To

David A Buchen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A Buchen owns 1 companies in total, including Amneal Pharmaceuticals Inc (AMRX) .

Click here to see the complete history of David A Buchen’s form 4 insider trades.

Insider Ownership Summary of David A Buchen

Ticker Comapny Transaction Date Type of Owner
AMRX Amneal Pharmaceuticals Inc 2019-01-01 SVP & Chief Legal Officer

David A Buchen Latest Holdings Summary

David A Buchen currently owns a total of 1 stock. David A Buchen owns 97,373 shares of Allergan PLC (AGN) as of August 29, 2013, with a value of $19 Million.

Latest Holdings of David A Buchen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGN Allergan PLC 2013-08-29 97,373 193.02 18,794,936

Holding Weightings of David A Buchen


David A Buchen Form 4 Trading Tracker

According to the SEC Form 4 filings, David A Buchen has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 10,000 shares on August 29, 2013, which brought David A Buchen around $1 Million.

Insider Trading History of David A Buchen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David A Buchen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David A Buchen Ownership Network

Ownership Network List of David A Buchen

No Data

Ownership Network Relation of David A Buchen


David A Buchen Owned Company Details

What does Amneal Pharmaceuticals Inc do?

Who are the key executives at Amneal Pharmaceuticals Inc?

David A Buchen is the SVP & Chief Legal Officer of Amneal Pharmaceuticals Inc. Other key executives at Amneal Pharmaceuticals Inc include Exec VP & Comm Optns Andrew S Boyer , 10 percent owner Tpg Gp A, Llc , and See Remarks Gustavo Pesquin .

Amneal Pharmaceuticals Inc (AMRX) Insider Trades Summary

Over the past 18 months, David A Buchen made no insider transaction in Amneal Pharmaceuticals Inc (AMRX). Other recent insider transactions involving Amneal Pharmaceuticals Inc (AMRX) include a net sale of 3,884,600 shares made by Tpg Gp A, Llc , and a net sale of 29,302 shares made by Andrew S Boyer .

In summary, during the past 3 months, insiders sold 0 shares of Amneal Pharmaceuticals Inc (AMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,913,902 shares of Amneal Pharmaceuticals Inc (AMRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,913,902 shares.

Amneal Pharmaceuticals Inc (AMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amneal Pharmaceuticals Inc Insider Transactions

No Available Data

David A Buchen Mailing Address

Above is the net worth, insider trading, and ownership report for David A Buchen. Currently GuruFocus does not have mailing address information for David A Buchen.

Discussions on David A Buchen

No discussions yet.